FDA approves Bavarian Nordic's monkeypox vaccine [Reuters]
BAVARIAN NORDIC R/I S/ADR (BVNRY)
NASDAQ:AMEX Investor Relations:
bavarian-nordic.com/investor.aspx
Company Research
Source: Reuters
FDA approves Bavarian Nordic's monkeypox vaccine - Reuters 2 Min Read (Reuters) - The U.S. Food and Administration on Tuesday approved Danish drugmaker Bavarian Nordic’s Jynneos, making it the first approved vaccine for preventing monkeypox disease. Monkeypox is a rare viral infection that does not spread easily from person to person. Infections have until recently been limited to central and western regions of Africa, but cases have been reported in Britain last year and in Singapore earlier this year. The approval triggers the award of a “priority review voucher” from the FDA to Bavarian Nordic, which can be used to speed up review of a future drug application. The company said it planned to sell the voucher to a third party. The U.S. in 2003 experienced an outbreak of monkeypox, which was the first time the disease was reported outside of Africa, the FDA said. Monkeypox infections are similar to smallpox, but typically milder. The disease begins with fever, headache, muscle aches a
Show less
Read more
Impact Snapshot
Event Time:
BVNRY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BVNRY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BVNRY alerts
High impacting BAVARIAN NORDIC R/I S/ADR news events
Weekly update
A roundup of the hottest topics
BVNRY
News
- US expected to increase biodefence spending under Trump, says vaccine maker Bavarian Nordic [Yahoo! Finance]Yahoo! Finance
- Bavarian Nordic Announces Interim Results for the First Nine Months of 2024 [Yahoo! Finance]Yahoo! Finance
- IDWeek 2024: strategic approaches and challenges in mpox vaccination [Yahoo! Finance]Yahoo! Finance
- Is Bavarian Nordic (BVNRY) Stock Undervalued Right Now? [Yahoo! Finance]Yahoo! Finance
- Bavarian Nordic's mpox vaccine to be trialled in pregnant women and infants [Yahoo! Finance]Yahoo! Finance